Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

Maria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, Natalia B Amaral, Pamella Indira Menezes, Saulo Musse Dib, Samara Libich Gigante, Maira N Benatti, Uebe C Rezek, Laerte L Emrich-Filho, Betania A A Sousa, Sergio C L Almeida, Rodrigo Luppino Assad, Flavio P Veras, Ayda Schneider, Tamara S Rodrigues, Luiz O S Leiria, Larissa D Cunha, Jose C Alves-Filho, Thiago M Cunha, Eurico Arruda, Carlos H Miranda, Antonio Pazin-Filho, Maria Auxiliadora-Martins, Marcos C Borges, Benedito A L Fonseca, Valdes R Bollela, Cristina M Del-Ben, Fernando Q Cunha, Dario S Zamboni, Rodrigo C Santana, Fernando C Vilar, Paulo Louzada-Junior, Rene D R Oliveira

10.1136/rmdopen-2020-001455

February 4, 2021

Reactive arthritis after COVID-19 infection

Keisuke Ono, Mitsumasa Kishimoto, Teppei Shimasaki, Hiroko Uchida, Daisuke Kurai, Gautam A Deshpande, Yoshinori Komagata, Shinya Kaname

10.1136/rmdopen-2020-001350

August 6, 2020

Evidences for a protective role of vitamin D in COVID-19

Maurizio Cutolo, Sabrina Paolino, Vanessa Smith

10.1136/rmdopen-2020-001454

December 28, 2020

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Victoria Furer, Christien Rondaan, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Annette de Thurah, Ulf Mueller-Ladner, Daphna Paran, Karen Schreiber, Klaus Warnatz, Nico M Wulffraat, Ori Elkayam

10.1136/rmdopen-2021-001594

February 24, 2021

Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines

Hendrik Schulze-Koops, Christof Specker, Alla Skapenko

10.1136/rmdopen-2020-001553

February 24, 2021

Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced

Christopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, Enrique R Soriano, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Federico Zazzetti, Ramanand A Subramanian, Xie L Xu, Qing C Zuraw, Shihong Sheng, Yusang Jiang, Prasheen Agarwal, Bei Zhou, Yanli Zhuang, May Shawi, Chetan S Karyekar, Atul Deodhar

10.1136/rmdopen-2020-001457

February 10, 2021

Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations

Myrto Kostopoulou, Antonis Fanouriakis, Kim Cheema, John Boletis, George Bertsias, David Jayne, Dimitrios T Boumpas

10.1136/rmdopen-2020-001263

July 22, 2020

Inflammaging as a link between autoimmunity and cardiovascular disease: the case of rheumatoid arthritis

Pedro Santos-Moreno, Gabriel Burgos-Angulo, Maria Alejandra Martinez-Ceballos, Alejandro Pizano, Dario Echeverri, Paula K Bautista-Niño, Anton J M Roks, Adriana Rojas-Villarraga

10.1136/rmdopen-2020-001470

January 19, 2021

Digital rheumatology in the era of COVID-19: results of a national patient and physician survey

Anna Kernder, Harriet Morf, Philipp Klemm, Diana Vossen, Isabell Haase, Johanna Mucke, Marco Meyer, Arnd Kleyer, Philipp Sewerin, Gerlinde Bendzuck, Sabine Eis, Johannes Knitza, Martin Krusche

10.1136/rmdopen-2020-001548

February 23, 2021

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial

Laurette van Boheemen, Samina Turk, Marian van Beers-Tas, Wouter Bos, Diane Marsman, Ed N Griep, Mirian Starmans-Kool, Calin D Popa, Alper van Sijl, Maarten Boers, Michael T Nurmohamed, Dirkjan van Schaardenburg

10.1136/rmdopen-2021-001591

March 7, 2021

Most Read Articles